FDA Clearance Tracker · P890003-S457
CareLink Instruments & DDMA, CareLink SmartSync Common Application
Last checked: Nov 20, 2026Latest source record: Apr 20, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Apr 20, 2023
Approved
Time to decision
167 days
Received Nov 4, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P890003-S457
- Device name
- CareLink Instruments & DDMA, CareLink SmartSync Common Application
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Nov 4, 2022
- Decided
- Apr 20, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P890003
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for two new models in the Micra Transcatheter Pacing System family, the Micra VR2 and the Micra AV2.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.